{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "CHO", "longName": "CHO Pharma, Inc.", "messageBoardId": "finmb_321539641", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChangePercent": -4.4213285, "regularMarketPrice": 73.5, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.6230769, "fiftyTwoWeekLow": 59.8, "fiftyTwoWeekHigh": 195.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.79, "sharesOutstanding": 183994000, "bookValue": 7.764, "fiftyDayAverage": 110.882, "fiftyDayAverageChange": -37.382004, "fiftyDayAverageChangePercent": -0.3371332, "twoHundredDayAverage": 138.403, "twoHundredDayAverageChange": -64.903, "twoHundredDayAverageChangePercent": -0.46894214, "marketCap": 13966691328, "priceToBook": 9.46677, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -3.4000015, "regularMarketTime": 1684134000, "regularMarketDayHigh": 78.3, "regularMarketDayRange": "72.3 - 78.3", "regularMarketDayLow": 72.3, "regularMarketVolume": 1001423, "regularMarketPreviousClose": 76.9, "bid": 73.7, "ask": 74.3, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 75.7, "averageDailyVolume3Month": 985159, "averageDailyVolume10Day": 3289265, "fiftyTwoWeekLowChange": 13.700001, "fiftyTwoWeekLowChangePercent": 0.22909701, "fiftyTwoWeekRange": "59.8 - 195.0", "fiftyTwoWeekHighChange": -121.5, "firstTradeDateMilliseconds": 1506560400000, "symbol": "6586.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building C", "address2": "7th Floor No. 99, Lane 130, Section 1 Academia Road, Nangang District", "city": "Taipei", "zip": "11571", "country": "Taiwan", "phone": "886 2 2655 8059", "fax": "886 2 2655 8069", "website": "https://www.chopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04 for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V07 glycan-based vaccines and drugs. The company was founded in 2013 and is based in Taipei City, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Chinh-Yi  Wu", "title": "GM & Board Member", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Chung-Yi  Wu", "title": "Pres", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ling-Mei  Wang", "title": "VP of Operation", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}